Literature DB >> 25736950

Early microlesion of viral encephalitis confirmed by galectin-3 expression after a virus inoculation.

Kazuhiro Kobayashi1, Masayuki Niwa2, Masato Hoshi3, Kuniaki Saito4, Kenji Hisamatsu5, Yuichiro Hatano5, Hiroyuki Tomita5, Tatsuhiko Miyazaki6, Akira Hara5.   

Abstract

Galectin-3 is a β-galactosidase-binding lectin which is important in cell proliferation and apoptotic regulation. Encephalomyocarditis virus (EMCV), which includes the Enterovirus genus, can cause not only acute myocarditis but also neuronal degeneration of central nervous system in various animals including mice. The pathophysiological role of galectin-3 in central nervous system following acute viral infection is not fully understood. The goal of this study is to determine the localization and time-course of galectin-3 expression after acute viral inoculation with EMCV. Galectin-3 is up-regulated in degenerated lesions of brain area including cerebellum, hippocampus, thalamus and cerebral hemisphere, 96 h after EMCV inoculation. At the same time, Iba-1 positive microglia was morphologically activated within and around the focus of infection. Interestingly, in cerebellum, the microlesions containing a few galectin-3 cells were detected in the immediate-early phase of infection, as early as 48 h after EMCV inoculation. Thus, our results indicate that galectin-3 expression may be a key mediator between viral infection and neuronal degeneration in central nervous system including cerebellum. Furthermore, detection of galectin-3 might be an early diagnostic method for neuronal degeneration after virus infection.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cerebellum; EMCV; Galectin-3; Microglia; Neuronal degeneration

Mesh:

Substances:

Year:  2015        PMID: 25736950     DOI: 10.1016/j.neulet.2015.02.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

2.  Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation.

Authors:  Kei Noguchi; Hiroyuki Tomita; Tomohiro Kanayama; Ayumi Niwa; Yuichiro Hatano; Masato Hoshi; Shigeyuki Sugie; Hideshi Okada; Masayuki Niwa; Akira Hara
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

Review 3.  Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases.

Authors:  Akira Hara; Masayuki Niwa; Kei Noguchi; Tomohiro Kanayama; Ayumi Niwa; Mikiko Matsuo; Yuichiro Hatano; Hiroyuki Tomita
Journal:  Biomolecules       Date:  2020-03-03

4.  Galectin-3 expression in hippocampal CA2 following transient forebrain ischemia and its inhibition by hypothermia or antiapoptotic agents.

Authors:  Kenji Hisamatsu; Masayuki Niwa; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Akihiro Hirata; Yuichiro Hatano; Hiroyuki Tomita; Akira Hara
Journal:  Neuroreport       Date:  2016-03-23       Impact factor: 1.837

Review 5.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.

Authors:  Salvatore Sciacchitano; Luca Lavra; Alessandra Morgante; Alessandra Ulivieri; Fiorenza Magi; Gian Paolo De Francesco; Carlo Bellotti; Leila B Salehi; Alberto Ricci
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

Review 6.  Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology.

Authors:  Akira Hara; Masayuki Niwa; Tomohiro Kanayama; Kei Noguchi; Ayumi Niwa; Mikiko Matsuo; Takahiro Kuroda; Yuichiro Hatano; Hideshi Okada; Hiroyuki Tomita
Journal:  Biomolecules       Date:  2020-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.